Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap15.99B
Enterprise Value15.77B
P/E Ratio20.57
PEG Ratio8.43
Price/Sales Ratio5.87
Price/Book Ratio3.38
Enterprise/Revenue5.8
Enterprise/EBITDA16.03

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.29
Operating Margin0.31
AD

Management Effectiveness

Return On Assets0.14
Return On Equity0.16

Income Statement

Revenue2.65B
Revenue/Share1.47
Gross Profit2B
EBITDA959.03M
Net Income735.19M
Diluted EPS0.44

Balance Sheet

Total Cash1.43B
Total Cash/Share0.86
Total Debt124.64M
Total Debt/Equity0.03
Current Ratio4.03
Book Value Per Share2.64

Price History

52-Week Change-16.33
52-Week High11.52
52-Week Low7.35
Moving Average 50 Days8.42
Moving Average 200 Days9.01

Statistics

Average Volume34.69M
Shares Outstanding1.67B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.25
Trailing Annual Dividend Yield2.9
Payout Ratio0.01
Last Split Factor6:5
Last Split DateMay 14, 2021
AD